OUTCOMES OF CORNEAL ALLERGENIC INTRASTROMAL RING SEGMENT (CAIRS) SURGERY
Dr David Gunn, Ophthalmologist
Cornea, Cataract and Refractive Surgeon, Queensland Eye Institute
& Focus Vision Clinic in Brisbane, Queensland
RESEARCHER PROFILE (Filmed in Brisbane, Queensland, Australian | June 2024)
Dr David Gunn is an ophthalmologist specialising in cornea, cataract, and refractive surgery at the Queensland Eye Institute and Focus Vision in Brisbane, Queensland. His journey into ophthalmology began during medical school, inspired by a mentor. He initially engaged in research on mouse glaucoma, exploring amacrine cells and their responses.
After completing his residency and gaining experience in eye casualty at the Royal Brisbane Hospital, David underwent four years of surgical training in the Queensland network. This was followed by a stint at the Bristol Eye Hospital in the UK, focusing on the cornea and anterior segment. Since returning to Queensland, he has concentrated on keratoconus research.
One of the pivotal moments in his career was the decision to specialise in cornea surgery, which included performing Australia’s first CAIRS procedure in May 2021. His current research examines outcomes for patients undergoing Corneal Allergenic Intrastromal Ring Segment (CAIRS) surgery.
Dr Gunn finds immense satisfaction in the immediate post-operative results he sees in patients, as visual acuity provides a tangible measure of success. He is passionate about introducing less invasive surgical techniques that lead to improvements in patients’ lives.
-
Environmental exposure to function of lung epithelial stem cell biology
Dr Clare Weeden has recently commenced as a Laboratory Head at WEHI in 2025, supported by the CSL Centenary Fellowship.
Dr Weeden specialises in lung epithelial cell biology in the context of homeostasis, inflammation, and lung cancer, particularly in people who don’t smoke. Her work endeavours to understand how past environmental exposures shape the responses of lung cells and the molecular mechanisms underlying this cellular recall, with the aim to develop novel early detection strategies for lung disease.
-
Muscle Cell Communication and Repair
Dr. William Roman is a Group Leader at the Australian Regenerative Medicine Institute (ARMI) at Monash University. He obtained his PhD from Paris Descartes University and Freie University of Berlin, focusing on nuclear positioning during skeletal muscle development. Dr. Roman’s research journey has taken him across the globe, including postdoctoral work in Barcelona, tissue engineering in Lisbon, and a brief stint at Stanford University.
At ARMI, Dr. Roman leads innovative research on intercellular communication within muscle organs. His work involves growing human muscles on chips to understand how skeletal muscle cells interact with neurons and tendons. This research aims to develop better models for studying muscle diseases, drug screening, and even applications in cellular agriculture and biorobotics.
-
Tyrosine Kinases in cancer recurrence
Dr Yu Yu leads the Oncology and Gynaecology Research Program at Curtin Medical Research Institute . Dr Yu is also a senior research fellow at Curtin Medical School.
Dr Yu Yu’s laboratory is working on better ways to treat cancers, particularly ovarian cancers which are resistant to conventional chemotherapy. The aims are for better informed treatment choice and reducing unnecessary exposure to ineffective chemotherapy and its potential adverse effects.
